Biotage® Initiator+ SP Wave is a versatile microwave system for the synthesis of both peptides and organic compounds. It can be used as a standalone single channel microwave peptide synthesizer or easily converted to a high-end microwave synthesizer.
Biotage® Initiator+ SP Wave is a versatile microwave system for the synthesis of both peptides and organic compounds. It can be used as a standalone single channel microwave peptide synthesizer or easily converted to a high-end microwave synthesizer
It is the ideal tool for the synthesis of peptides, peptidomimetics, PNA and for organic, medicinal, materials, nano and
polymer chemistry applications.
The instrument functions are controlled directly on the built in touch screen interface. Deprotection and washing steps are automated, while adding activated building blocks is performed manually. With this approach, intermediate reaction steps are easily monitored, and less equivalents can be added to reduce unnecessary waste of expensive reagents. Reactions are performed in disposable polypropylene reactor vials and mixing is achieved by vortex mixing.
This is a powerful development tool giving total control of the method development process using single or multi-step procedures.
When configured as a microwave synthesizer, the Initiator+ SP Wave is able to perform reactions at a temperature of 300 °C and 30 bar pressure and capable of processing up to eight reactions unattended. Reactions are performed in microwave glass vials and mixing is achieved by magnetic stirring.
The 8-position sample bed gives the user a compact automation solution to start scale-up process and library build-up. The 8-position system is useful in a multi-user environment or for queuing multiple reactions. Flexible
operation enables the use of both large and
small vials in combination at any time and in any order without manual intervention.
Part No. | Description | Pack Size | List Price | |
---|---|---|---|---|
356014 | Biotage® Initiator+ SP Wave - Microwave Peptide System EU | 1 | Add to quote/cart | |
356015 | Biotage® Initiator+ SP Wave - Microwave Peptide System US/JP | 1 | Add to quote/cart |
C-terminal peptide aldehydes are key components in oxime and hydrazine ligations and their synthesis is therefore very desirable. A well established method for the synthesis of C-terminal modified peptides including peptide aldehydes, is the backbone amide linker (BAL) strategy (Scheme 1). In this strategy, the first amino acid is anchored by reductive amination followed by acylation of the newly formed secondary amine. Thus, the growing peptide chain is anchored not through the C-terminal carboxyl but through a backbone amide nitrogen giving access to, in principle, any C-terminal modification.
Dr. Andrew Jamieson leads a team of peptide chemists at the University of Glasgow, where they synthesize complex molecules for chemical biology applications. An important tool that contributes to their success has been Biotage® Initiator+ Alstra™ microwave peptide synthesizer, and they are even breaking the dogma that only HPLC can be used for peptide purification, by using cutting edge reversed phase flash purification techniques provided by Biotage.
Dr. Aaron Muth from St. John’s University, Queens, New York speaks about his work in cancer research with Biotage lab equipment and specifically Biotage® Initiator+ Alstra™ and the SNAP Bio cartridges. As an Assistant Professor of Medicinal Chemistry, Dr. Muth and the members of his research group use this equipment every day.
Red Glead Discovery is a pre-clinical drug discovery CRO offering a broad range of services to Life Science clients. With a focus on small molecules and peptides, their drug discovery platform ranges from medicinal chemistry and synthesis to ADME and biology. In addition to the CRO business, they also perform research collaborations with various biotech and academic partners. We met with Richard E. Johnsson, Ph.D., Head of Peptide Chemistry at Red Glead Discovery, Lund, Sweden, where he told us about using Biotage products in his workflow.
Tokyo based PeptiDream Inc. is a company specializing in non-standard peptide therapeutics containing non-standard amino acids, and conducts research and development of new drug candidates. PeptiDream uses the peptide synthesizers Syro I and Biotage® Initiator+ Alstra™ for the synthesis of various kinds of peptides to support drug discovery and development.
The study of peptides, especially for therapeutic use, has grown significantly in recent years. However, producing peptides for such research is challenging, not just in the synthesis. The molecules must be visualized to allow synthetic approaches to be designed, and after synthesis the purification and isolation of peptides is not straightforward. In order to address these challenges, Biotage has developed a holistic approach to the entire peptide workflow via an automated solution, designed for dedicated peptide researchers and those new to the field.
A unique resin enabling the pharmaceutical industry to quickly develop and bring new complex peptide drugs candidates to market.
Durable and safe reactions at all times. Our high precision microwave vials are designed and tested to withstand pressures beyond 30 bar in a wide range of conditions.
NOTE: Biotage® Microwave Reaction Vials (in combination with the caps and septa) are ONLY to be used in Biotage Microwave Synthesizers.
Rapidly synthesize high quality peptides using microwave irradiation. A cost effective and versatile accessory for manual microwave peptide synthesis and cleavage when used with a Biotage® Initiator+ microwave synthesizer.
Biotage offers a variety of service agreements to choose from.
Biotage® Initiator+ SP Wave - Microwave Peptide System
Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development and diagnostics, analytical testing and water and environmental testing.
Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited.
Our customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.
Biotage is headquartered in Uppsala in Sweden and employs 497 people worldwide. The Group had sales of 1,232 MSEK in 2021 and our products are sold in more than 80 countries. Biotage’s share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm.
Copyright © 2021 Biotage